Anbio Biotechnology (NNNN) Net margin 2022–2025
Anbio Biotechnology (NNNN) net profit margin by fiscal year — reported net income divided by reported revenue.
74.1%FY2025 · since FY2022: 42.5% → 74.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 74.1% | +45.1 pp |
| FY2024 | 29.0% | -4.6 pp |
| FY2023 | 33.6% | -8.9 pp |
| FY2022 | 42.5% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice